A review of phase II trial designs for initial marker validation.
about
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewMolecular and clinical implementations of ovarian cancer mouse avatar modelsMethods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewDrug designs fulfilling the requirements of clinical trials aiming at personalizing medicine.Adaptive clinical trial designs in oncology.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.
P2860
Q26766584-A28F9AE3-B766-4675-B3B3-3D219CFEC9A4Q26786724-6D622A8D-298B-433F-9F2D-062119448BF7Q28086970-9F4414C8-E070-4BF2-A4D8-53E126D01844Q34535243-EBE38F5B-009E-4979-BD10-6B95E38554BAQ35206844-86EA3F47-A977-4578-A3FA-40BA95BF3BCCQ37731264-B7AAC0AE-F99A-4D4D-9EA4-2F2086F2820AQ55052878-EB29652D-E1C7-4ADA-AA9D-E7F697D6AF95
P2860
A review of phase II trial designs for initial marker validation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of phase II trial designs for initial marker validation.
@en
A review of phase II trial designs for initial marker validation.
@nl
type
label
A review of phase II trial designs for initial marker validation.
@en
A review of phase II trial designs for initial marker validation.
@nl
prefLabel
A review of phase II trial designs for initial marker validation.
@en
A review of phase II trial designs for initial marker validation.
@nl
P2860
P1476
A review of phase II trial designs for initial marker validation
@en
P2093
Ming-Wen An
Sumithra J Mandrekar
P2860
P304
P356
10.1016/J.CCT.2013.05.001
P407
P577
2013-05-08T00:00:00Z